SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Mary Shelley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Mary Shelley |
|---|
| Date of birth | 1797-08-30 |
|---|
| Identifiers | MRN HR-NI028-SYN-TD; SSN (made up) 000-28-6194 |
|---|
| Document date | 1849-09-29 |
|---|
| Author | Rosamund Achterberg-Ilesanmi, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Six-month review after resection: seizures, mood, and writing. [S]
History of Present Illness
Ms. Shelley returns about six months after resection of her meningioma. She has had no seizure since starting levetiracetam, about six and a half months ago, including during the stomach illness in August, when she vomited one dose. She drives again, keeps regular hours, and drinks little. Her mood is good; she finished her course with the counselor after eight sessions and says she can now speak of her old griefs without being undone by them. She writes every morning and has nearly finished her travel book. She has no headaches. [S]
| Element | Detail |
|---|
| Seizures | None since starting levetiracetam |
| Mood | Good; counseling completed after eight sessions |
| Writing | Every morning; travel book nearly finished |
| Gastroenteritis | Resolved in four days |
Review of Systems
| System | Result | Finding |
|---|
| Neurological | Negative | No seizures, aura, headaches, or weakness |
| Gastrointestinal | Negative | Bowels normal since August |
| Psychiatric | Negative | Mood good; no irritability; no thoughts of suicide |
| Constitutional | Negative | Weight stable; sleeping well |
4 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Levetiracetam 500 mg oral tablet, one tablet by mouth twice a day | One tablet twice a day | Oral route | 1849-03-17 | active | S |
| Dexamethasone 4 mg oral tablet, one tablet twice a day for three days before surgery, then tapered and stopped over ten days after surgery | One tablet twice a day, then tapering | Oral route | 1849-04-04 to 1849-04-17 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for headache or wound pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 1848-09-01 | active | S |
| Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for vomiting, for up to two days | One tablet every 8 hours as needed for vomiting | Oral route | 1849-08-11 to 1849-08-13 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1849-09-29 | Body height | 160 | cm | S |
| 1849-09-29 | Body weight | 57.4 | kg | S |
| 1849-09-29 | Body mass index (BMI) [Ratio] | 22.4 | kg/m2 | S |
| 1849-09-29 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1849-09-29 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1849-09-29 | Heart rate | 68 | /min | S |
| 1849-09-29 | Respiratory rate | 14 | /min | S |
| 1849-09-29 | Body temperature | 36.5 | Cel | S |
| 1849-09-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1849-09-29 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | | | S |
| 1849-09-29 | Total score [MoCA] | 29 | {score} | | | S |
| 1849-09-29 | Creatinine [Mass/volume] in Serum or Plasma | 0.76 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1849-09-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1844)/1.73 sq M | 95 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
Physical Exam
Vital signs recorded on 1849-09-29; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Well |
| Neurological | Normal: speech, strength, finger tapping, reflexes, and gait |
| Mental status | Bright, articulate, and reflective; MoCA 29 |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Headaches, worse in the morning, for about two years, with episodes over six months of tingling and weakness of the right hand and leg lasting a few minutes, one with twitching of the right fingers and one with difficulty finding words; mild right-hand weakness on examination; cause not yet established; urgent MRI and EEG booked | resolved | confirmed |
R29.818 | S — Synthetic presenting concern at the index visit, superseded by the MRI and EEG diagnosis; her documented headaches with transient right-sided paralysis from 1839 are echoed. |
| Meningioma of the left frontoparietal convexity over the hand area of the motor cortex, 3.1 x 2.7 x 2.6 cm, with moderate vasogenic edema; resected (Simpson grade I); meningothelial meningioma, CNS WHO grade 1; synthetic modern counterpart of the supposed tumour of the left hemisphere on her death certificate | active | confirmed |
D32.0 | S — Synthetic modern diagnosis. Her symptoms and the certificate's wording are documented (D); a brain tumour is a retrospective interpretation (R) disputed by the hemiplegic migraine and stroke hypothesis, and no tissue exists, so this meningioma is not presented as her historical diagnosis. |
| Focal epilepsy due to the left convexity meningioma: focal aware sensory and motor seizures of the right hand and arm, one with speech arrest; EEG with left central sharp waves; on levetiracetam | active | confirmed |
G40.109 | S — Synthetic modern diagnosis echoing her documented convulsive seizures and transient right-sided paralysis; the hemiplegic migraine interpretation is recorded as R. |
| Acute viral gastroenteritis for two days, with vomiting of one levetiracetam dose, mild dehydration, and no seizure; resolved in four days | resolved | confirmed |
A08.4 | S — Synthetic common illness chosen to teach antiseizure medicine adherence during vomiting; it echoes no documented illness. |
Assessment and Plan
- Focal epilepsy on levetiracetam (G40.109). Seizure-free for six and a half months; kidney function normal (creatinine 0.76 mg/dL, eGFR 95). PHQ-9 4; MoCA 29. [S]
- Continue levetiracetam 500 mg twice a day.
- At one year after surgery: EEG and a shared decision about tapering.
- Meningioma, CNS WHO grade 1, after resection (D32.0). No symptoms of recurrence. [S]
- MRI one year after surgery.
- Viral gastroenteritis (A08.4). Resolved without complications or seizures. [S]
- Keep the plan for vomited doses in her diary.
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|
| Self-management | Seizure diary, triggers (sleep loss, alcohol, missed doses), and seizure first aid | Every visit | Completed today | No seizures in six and a half months; one vomited dose in August was managed by plan |
| Survey | PHQ-9, with a question about irritability on levetiracetam | Every visit while on levetiracetam and during cancer treatment | Completed today | 4, minimal; counseling completed |
| Survey | GAD-7 | Every visit during the diagnostic and treatment phase; then as needed | Not indicated | Mild at the last visit and no anxiety reported now; to be repeated if symptoms return |
| Survey | Cognitive screen after brain surgery | Baseline and after treatment | Completed today | MoCA 29, up from 27 before surgery |
| Laboratory | Kidney function on levetiracetam | Baseline, then periodically, because the drug is cleared by the kidneys | Completed today | Creatinine 0.76 mg/dL; eGFR 95 |
| Imaging | Surveillance MRI | Yearly for five years after the three-month scan | Due | One year after surgery |
| Examination | EEG before any taper | Before deciding to stop an antiseizure medicine | Due | At one year after surgery |
Goal progress:
- A diagnosis within two weeks, explained in plain words with the images and reports. Outcome by 1849-03-17: MRI and EEG within a week; diagnosis explained at two weeks with the images [S]
- No further seizures. In progress; target 1850-04-07 [S]
- Full use of the right hand and return to writing every morning. Outcome by 1849-09-29: Grip equal on both sides by three months; writing every morning [S]
- Decide on treatment herself after hearing the options, benefits, and harms. Outcome by 1849-03-17: Chose resection after observation and radiosurgery were explained [S]
- Mood and grief supported: PHQ-9 below 5 and a counselor available. Outcome by 1849-09-29: PHQ-9 4 at six months; completed eight sessions with the neuro-oncology counselor [S]
Guideline basis: EANO guideline on the diagnosis and management of meningiomas. Goldbrunner R, et al. Neuro Oncol 2021;23(11):1821-1834 (2021); Evidence-based guideline: Management of an unprovoked first seizure in adults. Krumholz A, et al. Neurology 2015;84(16):1705-1713 (2015); SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Walbert T, et al. Neuro Oncol 2021;23(11):1835-1844 (2021); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (depression screening and PHQ-9 follow-up) (2026)
Follow-up: Preventive visit next month; MRI and EEG at one year after surgery with a review of levetiracetam. Next scheduled visit 1849-10-20: adult preventive visit. [S]